QPS is well known as a leading CRO for CNS drug development. The availability of the most predictive disease models and unparalleled experience with studies performed for biopharmaceutical companies of all sizes turn QPS into the first choice for most research needs.
Studies determining Absorption, Distribution, Metabolism and Excretion (ADME) patterns in laboratory animals and humans are an integral part of the Drug Metabolism and Pharmacokinetics (DMPK) services provided by QPS. These studies are employed at the discovery, candidate selection,
Our commitment is to provide you, our valued customers, with a fast and reliable route to clinical phase I-II studies. We offer you a wide range of toxicity and DMPK studies as well as other preclinical safety tests that are essential for your preclinical drug development programs. As our valued client...
Whether your focus is on small molecules, proteins, antibodies, vaccines or oligonucleotides, QPS provides you with a full range of bioanalytical solutions to support the entire spectrum from early discovery, to IND-enabling ADME, to clinical studies.
At QPS, translational medicine brings together leading-edge technologies and pharmaceutical R&D experience to create a business service unit that works efficiently to advance your drug development program.
Our Clinical Development Team combines scientific expertise, open communication and trust to build lasting relationships with our clients. We offer collaborative solutions throughout the entire clinical development process to provide you with high enrollment rates, industry-best timelines, high-quality data, and a competitive price.
‘Biosimilar’ or ‘Follow-on Biologic’ are terms given to manufactured biological molecules, however due to the complexity of biologics, the product made can only be similar not identical to its reference molecule.
QPS provides essential preclinical and clinical research services to help pharmaceutical and biotechnology companies around the globe accelerate the discovery and development of drugs to prevent, treat and cure brain diseases, with a special focus on age-related neurodegenerative disorders such as Alzheimer’s and Parkinson’s Disease.
Typically, vaccine trials are conducted at multi-center Phase III sites that specialize in various patient populations. Unfortunately, many of these sites can only supply a small number of subjects and require weeks if not months to enroll subjects. Some vaccine developers complain that certain sites even enroll subjects that do not meet inclusion/exclusion criteria.
A well-conceived and executed IND-enabling preclinical program will provide you with a detailed assessment of your drug candidate and the most cost-effective and timely pathway to filing an IND.
A well-conceived and executed preclinical and clinical radiolabelled ADME program will provide you with a detailed assessment of the total fate (mass balance, route and rate of excretion, tissue distribution, metabolic pathways, and identity and quantity of metabolites) of your drug candidate to support regulatory submissions.
QPS draws on the considerable expertise of Paul Lehman in the field of topical and transdermal pharmacokinetics and safety testing to provide our clients with a wide range of specialized research services for the pharmaceutical and toxicology industries.
To facilitate a smooth project flow from initiation through the issuance of the final study report, QPS assigns a dedicated project manager (PM) to assist you every step of the way.
QPS encourages its scientists to publish and disseminate the results of their high quality research which is mostly done in close collaboration with our clients. QPS also expects of its scientists that they will engage in the process of publishing and dissemination of their work responsibly and with an awareness of the consequences for QPS’ clients of any such dissemination in the wider media.
The point of pharmaceutical R&D is to drive as many new medicines over the goal line, bring them to market and make them available to patients. Ultimately, then, we measure the success of our daily activities on behalf of the pharmaceutical R&D community by the number of new drug approvals we obtain from worldwide regulatory authorities. Every quarter, QPS proudly publishes a list of original new drug approvals we helped many of our industry partners/sponsors earn from the FDA & EMA.
Trust fund seitan letterpress, keytar raw denim keffiyeh etsy art party before they sold out master cleanse gluten-free squid scenester freegan cosby sweater. Fanny pack portland seitan DIY, art party locavore wolf cliche high life echo park Austin. Cred vinyl keffiyeh DIY salvia PBR, banh mi before they sold out farm-to-table VHS viral locavore cosby sweater. Lomo wolf viral, mustache readymade thundercats keffiyeh craft beer marfa ethical. Wolf salvia freegan, sartorial keffiyeh echo park vegan.
May 22-23, 2018
May 7-10, 2018May 1-2, 2018Apr 14-19, 2018
+1 512 350 2827
+1 302 369 5602
More